Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Prefaut

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1995
[Evolution of breathing pattern and ventilation at maximal exercise during growth. Definition of reference values]J Prioux, J Mercier, M Ramonatxo, et al.
Revue Des Maladies Respiratoires|March 13, 2002
[Maximal oxygen uptake in healthy children: factors of variation and available standards]S Matecki, J Prioux, F Amsallem, et al.
Revue Des Maladies Respiratoires|November 28, 2006
[Management of COPD: feasability]R Benali, H Bensaad, I Harrabi, et al.
Revue Des Maladies Respiratoires|January 1, 1984
[Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study]D Bourgouin-Karaouni, M Ramonatxo, F B Michel, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Effects of moderate exercise on the pharmacokinetics of caffeineK Collomp, F Anselme, M Audran, et al.
Revue Des Maladies Respiratoires|June 24, 2010
[The VQ11, a short health-related quality of life questionnaire for routine practice in COPD patients]G Ninot, F Soyez, S Fiocco, et al.
Metabolism: Clinical and Experimental|July 19, 2003
Serum levels of insulin-like growth factor-I (IGF-I), and IGF-binding proteins-1 and -3 in middle-aged and young athletes versus sedentary men: relationship with glucose disposalJ Manetta, J F Brun, C Fedou, et al.
La Nouvelle Presse Medicale|February 2, 1974
[A.G.M. immunoglobulins and chronic bronchopneumopathies]F B Michel, J M Mellet, C Prefaut, et al.
The American Review of Respiratory Disease|December 1, 1986
Effects of adenosine triphosphate on pulmonary circulation in chronic obstructive pulmonary disease. ATP: a pulmonary vasoregulator?S J Gaba, D Bourgouin-Karaouni, P Dujols, et al.
International Journal of Sports Medicine|October 1, 1994
Sickle cell trait as a limiting factor for high-level performance in a semi-marathonD Le Gallais, C Prefaut, J Mercier, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1995
[Evolution of breathing pattern and ventilation at maximal exercise during growth. Definition of reference values]J Prioux, J Mercier, M Ramonatxo, et al.
Revue Des Maladies Respiratoires|March 13, 2002
[Maximal oxygen uptake in healthy children: factors of variation and available standards]S Matecki, J Prioux, F Amsallem, et al.
Revue Des Maladies Respiratoires|November 28, 2006
[Management of COPD: feasability]R Benali, H Bensaad, I Harrabi, et al.
Revue Des Maladies Respiratoires|January 1, 1984
[Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study]D Bourgouin-Karaouni, M Ramonatxo, F B Michel, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Effects of moderate exercise on the pharmacokinetics of caffeineK Collomp, F Anselme, M Audran, et al.
Revue Des Maladies Respiratoires|June 24, 2010
[The VQ11, a short health-related quality of life questionnaire for routine practice in COPD patients]G Ninot, F Soyez, S Fiocco, et al.
Metabolism: Clinical and Experimental|July 19, 2003
Serum levels of insulin-like growth factor-I (IGF-I), and IGF-binding proteins-1 and -3 in middle-aged and young athletes versus sedentary men: relationship with glucose disposalJ Manetta, J F Brun, C Fedou, et al.
La Nouvelle Presse Medicale|February 2, 1974
[A.G.M. immunoglobulins and chronic bronchopneumopathies]F B Michel, J M Mellet, C Prefaut, et al.
The American Review of Respiratory Disease|December 1, 1986
Effects of adenosine triphosphate on pulmonary circulation in chronic obstructive pulmonary disease. ATP: a pulmonary vasoregulator?S J Gaba, D Bourgouin-Karaouni, P Dujols, et al.
International Journal of Sports Medicine|October 1, 1994
Sickle cell trait as a limiting factor for high-level performance in a semi-marathonD Le Gallais, C Prefaut, J Mercier, et al.
Pageof 11